Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series
- PMID: 38597844
- PMCID: PMC11097960
- DOI: 10.1016/j.jcin.2024.01.284
Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series
Abstract
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than 60 years by 2030, interventional cardiologists are increasingly involved in providing complex care for older individuals. Although procedural aspects remain their main clinical focus, interventionalists frequently encounter age-associated risks that influence eligibility for invasive care, decision making during the intervention, procedural adverse events, and long-term management decisions. The unprecedented growth in transcatheter interventions, especially for structural heart diseases at extremes of age, have pushed age-related risks and implications for cardiovascular care to the forefront. In this JACC state-of-the-art review, the authors provide a comprehensive overview of the aging process as it relates to cardiovascular interventions, with special emphasis on the difference between chronological and biological aging. The authors also address key considerations to improve health outcomes for older patients during and after their invasive cardiovascular care. The role of "gerotherapeutics" in interventional cardiology, technological innovation in measuring biological aging, and the integration of patient-centered outcomes in the older adult population are also discussed.
Keywords: age-associated risks; aging; cardiovascular disease; risk factors; transcatheter therapeutics.
Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures This study was funded in part by a mentored patient-oriented research career development award from the National Heart, Lung, and Blood Institute (K23-HL153771). Dr Damluji has received research funding from the Pepper Scholars Program of the Johns Hopkins University Claude D. Pepper Older Americans Independence Center, funded by National Institute on Aging grant P30-AG021334; a mentored patient-oriented research career development award from the National Heart, Lung, and Blood Institute (K23-HL153771); National Institute of Aging grant R01-AG078153; and the Patient-Centered Outcomes Research Institute. Dr Nanna has received current research support from the American College of Cardiology Foundation, supported by the George F. and Ann Harris Bellows Foundation, the Patient-Centered Outcomes Research Institute, the Yale Claude D. Pepper Older Americans Independence Center (grant P30AG021342), and National Institute on Aging grant R03AG074067 (Grants for Early Medical/Surgical Specialists’ Transition to Aging Research award); and is a consultant for HeartFlow and Merck. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures


Similar articles
-
TAVR in Older Adults: Moving Toward a Comprehensive Geriatric Assessment and Away From Chronological Age: JACC Family Series.JACC Adv. 2024 Apr;3(4):100877. doi: 10.1016/j.jacadv.2024.100877. Epub 2024 Apr 8. JACC Adv. 2024. PMID: 38694996 Free PMC article.
-
A Geriatric Approach to Percutaneous Coronary Interventions in Older Adults, Part II: A JACC: Advances Expert Panel.JACC Adv. 2023 Jul;2(5):100421. doi: 10.1016/j.jacadv.2023.100421. Epub 2023 Jul 28. JACC Adv. 2023. PMID: 37575202 Free PMC article.
-
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615. Circulation. 2007. PMID: 17502590 Review.
-
Noninvasive Techniques for Tracking Biological Aging of the Cardiovascular System: JACC Family Series.JACC Cardiovasc Imaging. 2024 May;17(5):533-551. doi: 10.1016/j.jcmg.2024.03.001. Epub 2024 Apr 8. JACC Cardiovasc Imaging. 2024. PMID: 38597854 Review.
-
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.J Am Coll Cardiol. 2022 Feb 8;79(5):482-503. doi: 10.1016/j.jacc.2021.11.029. J Am Coll Cardiol. 2022. PMID: 35115105 Free PMC article. Review.
Cited by
-
The Impact of Cognitive Impairment on Cardiovascular Disease.J Am Coll Cardiol. 2025 Jul 1;85(25):2472-2491. doi: 10.1016/j.jacc.2025.04.057. J Am Coll Cardiol. 2025. PMID: 40562512 Free PMC article. Review.
-
Association of Frailty With Readmissions and Outcomes After Impella Mechanical Circulatory Support.CJC Open. 2025 Apr 22;7(7):972-985. doi: 10.1016/j.cjco.2025.04.011. eCollection 2025 Jul. CJC Open. 2025. PMID: 40698301 Free PMC article.
-
Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus.JACC Adv. 2025 Jun;4(6 Pt 1):101784. doi: 10.1016/j.jacadv.2025.101784. Epub 2025 May 14. JACC Adv. 2025. PMID: 40373524 Free PMC article. Review.
-
Benefits of Cardiac Rehabilitation: Mechanisms to Restore Function and Clinical Impact.Circ Res. 2025 Jul 7;137(2):255-272. doi: 10.1161/CIRCRESAHA.125.325705. Epub 2025 Jul 3. Circ Res. 2025. PMID: 40608851 Review.
-
Transgender healthcare: metabolic outcomes and cardiovascular risk.Diabetologia. 2024 Nov;67(11):2393-2403. doi: 10.1007/s00125-024-06212-6. Epub 2024 Jul 3. Diabetologia. 2024. PMID: 38958699 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical